Objective: The hepatic cell line LX-2 was originally described in 2005 as a novel tool to study
mechanisms of hepatic fibrogenesis and the testing of antifibrotic compounds [1].
It was established by immortalisation with the Simian Vacuolating Virus 40 (SV40)
transforming (T) antigen and subsequent propagation in low serum conditions. Although
this immortalized line is used in an increasing number of studies [2], a detailed
genotypic characterisation that is mandatory for immortalized cell lines is still
lacking. Design: In this study we attempt to describe the genetic characteristics
and expression attributes of LX-2 cells to establish a reliable platform for explaining
its cellular behaviour. Results: We established a single-locus short tandem repeat (STR) signature for the cell line
and characterized the LX-2 karyotype by several cytogenetic and molecular cytogenetic
techniques. Spectral karyotyping (SKY) revealed that LX-2 have marked heterogeneity
with some chromosomal aberrations. However, despite some complexity and genetic variability,
a few recurrent translocations have been identified that are specific for LX-2 and
therefore suitable for proper identity testing. In addition, we found that this LX-2
cells express collagen type IV, collagen type I, fibronectin, vimentin, desmin, α-smooth
muscle actin, connective tissue growth factor (CTGF), Id2, p21 and the complete set
of TGF-β receptors including TβRI, TβRII and the accessory receptor endoglin (CD105)
supporting the notion that this cell line originated from hepatic stellate cells.
Conclusions: Our study provides criteria for cellular authentication of LX-2, and offers functional
clues underlying its phenotypic and genotypic features. The provided information will
increase the attraction for LX-2 cells in liver research and allow easy cellular authentication
to avoid potential false experimental outcomes and scientific misinterpretation in
studies in which LX-2 are employed.
References:
[1] Xu L et al. GUT 2005;54:142–151.
[2] Herrmann J et al. J Cell Mol Med 2007;11:704–722.